What can we help you find?

Leading the way in transplantation

Filter results for:

Transplant International goes Gold Open Access

The European Society for Organ Transplantation (ESOT) has announced the transition of Transplant International from Hybrid access to Gold Open Access in partnership with Frontiers. Transplant International is the premier journal publishing the key basic science and clinical developments in organ replacement medicine and will transfer from the publisher Wiley to Frontiers’ Open Science Platform from January 1, 2022....

Read

July 27, 2021 | General

Overview

Transplant International is the official journal of the European Society for Organ Transplantation (ESOT). Transplant International aims to be the premier journal publishing the key basic science and clinical developments in organ replacement medicine, including all aspects of transplantation, organ reconditioning, cell therapy, regenerative medicine, bioengineering and artificial organs.

Because they concern the unrelated field of onco-hematology, Transplant International does not accept submissions in the field of hematopoietic stem cell transplantation (HSCT).

Aims and Scope

The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. Papers submitted to the journal are subject to peer review.

Editorial Board

Editor-in-Chief

Thierry Berney, University of Geneva, Switzerland

Deputy Editors-in-Chief

Nuria Montserrat, Institute for Bioengineering of Catalonia, Spain
Maarten Naesens, KU Leuven, Belgium
Stefan Schneeberger, Medical University of Innsbruck, Austria

Social Media Editor

Maria Irene Bellini, Sapienza Università di Roma, Italy

Statistical Editor

Thomas Neyens, KU Leuven, Belgium

Associate Statistical Editor

Maarten Coemans, KU Leuven, Belgium

Executive Editors

Cristiano Amarelli, Vanvitelli University, Italy
Frederike Ambagtsheer, Erasmus MC, The Netherlands
Federica Casiraghi, Mario Negri Institute for Pharmacological Research, Italy
Christine Falk, Hannover Medical School, Germany
John Forsythe, University of Edinburgh, UK
Marius Miglinas, Vilnius University, Lithuania
Arne Neyrinck, KU Leuven, Belgium
Nazia Selzner, University of Toronto, Canada
Olivier Thaunat, University of Lyon, France

Associate Editors

Coby Annema, University of Groningen, The Netherlands
Jutta Arens, Enschede, University of Twente, The Netherlands
Wolf O. Bechstein, Frankfurt University Hospital and Clinics, Germany
Cristina Berastegui, Universidad Autonoma da Barcelona, Spain
Ekaterine Berishvili, Ilia State University, Georgia
Oriol Bestard, University of Barcelona, Spain
Olivia Boyer, Hospital Necker Enfants Malades, France
Margarita Brida, University Hospital Center Zagreb, Croatia
Sophie Brouard, Center for Research in Transplantation and Immunology, France
Jadranka Buturovic-Ponikvar, University Medical Center, Slovenia
Sanem Cimen, Health Sciences University of Turkey, Turkey
Sarwa Darwish Murad, Erasmus MC, The Netherlands
Farsad-Alexander Eskandary, Medical University of Vienna, Austria
Stuart M. Flechner, Cleveland Clinic Lerner College of Medicine, USA
Lucrezia Furian, University of Padova, Italy
Maddalena Giannella, Policlinico Sant’Orsola Malpighi, Italy
Ilkka Helanterä, Helsinki University Central Hospital, Finland
Sarah Hosgood, University of Cambridge, UK
Nichon Jansen, Dutch Transplant Foundation, The Netherlands
Katja Kotsch, Charité – Universitätsmedizin Berlin, Germany
Cécile Legallais, Technological University of Compiègne, France
Wai H. Lim, Sir Charles Gairdner Hospital, Australia

DEI Statement

At Transplant International, we believe that diversity is the essence of humankind. We value engagement and inclusion at all stages of science communication and dissemination, from the submission of research manuscripts, through the editorial and review process and on to publication. We welcome submissions from applicants of all ethnicities, nationalities, religions, gender identities, sexual orientations or other individual status, and are committed to eliminating the influence of any bias in our processes.

We recognise that this endeavour requires an ongoing commitment; the journal will continually review its practices in this regard and welcomes any feedback from our authors and community.

Open Access Statement

Transplant International provides online free gold open access to the journal and all of its research publications.

Open Access funder and institutional mandates: Transplant International is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Transplant International. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Copyright Statement

Under the Conditions for Website Use and the General Conditions for Authors, authors of articles published in Transplant International retain copyright on their articles, except for any third-party images and other materials added by Transplant International, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. Visitors may also download and forward articles subject to the citation requirements and subject to any fees Transplant International’s publisher, Frontiers, may charge for downloading licenses. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially.

Quality

Each Transplant International article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. Transplant International encourages authors to consult the instructions for authors guidelines prior to submission.